on AMOEBA (EPA:ALMIB)
Amoéba and Koppert extend their partnership to arboriculture in Europe
Amoéba, a company specializing in natural microbiological solutions, and Koppert, a world leader in biological crop protection, have announced the expansion of their distribution agreement to fruit growing in 19 European countries. This partnership aims to address the challenges faced by fruit growers regarding fungal diseases, exacerbated by climate change, and to compensate for the decline in conventional solutions.
With AXPERA technology, the two companies are targeting 40% of orchard areas in Europe, hoping to boost their sales figures. Initial trials on apple trees have shown over 90% efficacy against diseases such as scab and powdery mildew. Commercialization is planned for 2029, subject to obtaining the necessary approvals.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AMOEBA news